Blood test study for ankylosing spondylitis and psoriatic arthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial is studying a blood marker called glutathione peroxidase 4 in people with ankylosing spondylitis or psoriatic arthritis. It aims to understand inflammation and may help with future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of ankylosing spondylitis or psoriatic arthritis.
- You must be over 18 years old.
- You cannot have other autoimmune rheumatic diseases (like lupus or rheumatoid arthritis).
- You cannot have severe liver or kidney problems, a blood disorder, active infection, cancer, or a wasting disease.
- You cannot be taking certain medications (sulfasalazine, artemisinin, statins, or erastin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This trial studies whether adding a biologic medicine (targeted therapy) can help people with active spondyloarthritis when standard anti-inflammatory pain medicines (NSAIDs) have not worked well enough. It focuses on people with ongoing symptoms despite trying at least two NSAIDs.
This research study measures a specific blood protein (IL-41) in people with two types of inflammatory arthritis: ankylosing spondylitis (which affects the spine) and psoriatic arthritis (which affects joints and skin). Understanding this marker may help doctors better diagnose and monitor these conditions.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This study looks at a specific enzyme (15-hydroxyprostaglandin dehydrogenase) in people with osteoarthritis or ankylosing spondylitis. It may help researchers understand these conditions better and find new treatment targets.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
Hear when a new Spondyloarthropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.